e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Pleural techniques and diagnosis of peripheral lung nodules
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interleukin-8 and other mediators are related to tumour burden in malignant pleural effusions (MPE)
A. Montes Worboys, E. Arellano Orden, D. Rodriguez Rodriguez, J. Martin Juan, F. Rodriguez Panadero (Sevilla, Spain)
Source:
Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules
Session:
Pleural techniques and diagnosis of peripheral lung nodules
Session type:
Thematic Poster Session
Number:
738
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Montes Worboys, E. Arellano Orden, D. Rodriguez Rodriguez, J. Martin Juan, F. Rodriguez Panadero (Sevilla, Spain). Interleukin-8 and other mediators are related to tumour burden in malignant pleural effusions (MPE). Eur Respir J 2007; 30: Suppl. 51, 738
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
N3 hilar sampling decision in the staging of mediastinal lung cancer
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Related content which might interest you:
The value of IL6 in differentiation between malignant and non malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Comparison in effectiveness and proinflammatory mediators between talc, doxycycline and tetracycline for pleurodesis in malignant pleural effusions (MPE)
Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy
Year: 2006
Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007
A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma
Source: Eur Respir J 2010; 36: 1099-1105
Year: 2010
LSC Abstract – Host-environmental IL-1b drives mutant KRAS-IKKa addiction in malignant pleural effusion
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
Interleukin-16 in tuberculous and malignant pleural effusions
Source: Eur Respir J 2005; 25: 605-611
Year: 2005
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Association between proinflammatory cytokines (TNFa and IL8) and fibrinolytic system in malignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 494s
Year: 2004
Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE)
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001
Non-classical monocytes potentiates the pathogenesis of malignant pleural effusion via the production of IL-1ß
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Osteopontin is important for malignant pleural effusion formation
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004
Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
Metastatic pleural effusions (mpes)
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008
Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011
C-reactive protein in differentiation between tuberculous and malignant pleural effusions
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept